INKT Earnings

Quarterly EPS
$-0.46
Q3 2024
$-0.62
Q4 2024
$-0.70
Q1 2025
$-1.06
Q2 2025
$-0.65
Q3 2025
$-0.55
Q4 2025
$-0.57
Q1 2026
$-0.62
Q2 2026
Latest RevenueN/A
Latest Net Income-3128201
EPS & Revenue Trend
PeriodEPSRevenueNet IncomeRev YoYEPS YoY
Q2 2026-$0.620-3128201+41.5%
Q1 2026-$0.570-2742368+18.6%
Q4 2025-$0.550-2602103+11.3%
Q3 2025-$0.650-2887709-41.3%
Q2 2025-$1.060-4237751-45.2%
Q1 2025-$0.700-2766697+36.4%
Q4 2024-$0.620-2463104+60.8%
Q3 2024-$0.460-1806597+69.3%
Q2 2024-$0.730-2701806
Q1 2024-$1.100-3813295
Q4 2023-$1.580-5458597
Q3 2023-$1.500-5116266
MiNK Therapeutics (INKT) — Earnings